Eiken

  • Site Map
  • Contact Us
  • En|Jp
  • About Eiken
  • Products
  • Our Fields
  • Publication
  • Research and Development
  • Investor Relations
  • Sustainability

About Us

About Us

  • Message from the CEO
  • Our Management Philosophy
  • Brand Story
  • Our Business
  • Company Profile
  • Offices/Group Company
  • Executives
  • Eiken's History
  • Management Plan
  • PR Videos

Products

Products

  • Fecal Testing "OC-SENSOR"
  • Molecular Test “LAMP”
  • Immunological and Serological Reagents “LZ Test Eiken”
  • Veterinary “VET-SAA Eiken”

Our Fields

Our Fields

  • Gastroenterology
  • Infectious diseases
  • Veterinary

Publication

Publication

  • Fecal Immunochemical Test
  • Gastric Cancer Risk Assessment Test (ABCD risk classification)
  • Veterinary
  • Molecular Test "LAMP"

Research and Development

Research and Development

  • R&D Vision
  • EIKEN’s Technologies
  • R&D Structure
  • Intellectual Property

Investor Relations

Investor Relations

  • Message form the CEO
  • Management Plan
  • Financial Data or Financial Highlites
  • IR Library
  • Stakeholder Message
  • Stock Information
  • IR Calender
  • IR News
  • IR Policy
  • Operating Risks

Sustainability

Sustainability

  • CEO Message
  • Eiken and Sustainability
  • ESG Data
  • Integrated Report
  • Stakeholder Message
  • External Evaluation

Medical

  • Improving Access to Healthcare
  • Solutions to Medical Issues
  • Pursuing Quality and Establishing Sustainable Supply Chains

Environment

  • Environmental Management
  • Responding to Climate Change
  • Contributing to a Recycling-Oriented Society

Social

  • Respecting Human Rights and Diversity
  • Employee Engagement and Personnel Training
  • Boosting Health and Ensuring Safety and Hygiene

Governance

  • Achieving Transparent and Sound Governance
  • Rigorous Compliance and Thorough Corruption Prevention
  • Establishing Risk Management
  • En
  • Jp

News

  1. TOP
  2. News

Year:

Category:

SubCategory:

  • 2026.05.12 CorporateSR, IRNotice regarding Election of Director Candidates
  • 2026.05.12 CorporateSR, IRFinancial Results for FY2025 and Management Plan
  • 2026.05.12 CorporateSR, IRConsolidated Financial Results for the Fiscal Year Ended March 31, 2026
  • 2026.05.12 CorporateSR, IRNotice Regarding Opinion of the Company’s Board of Directors on the Shareholder Proposal
  • 2026.05.12 CorporateSR, IRNotice Regarding Changes to Management Plan
  • 2026.05.12 CorporateSR, IRNotice Concerning Change in Representative Executive Officer
  • 2026.04.24 CorporateReleaseWorld Malaria Day  “Driven to End Malaria: Now We Can. Now We Must.”
  • 2026.04.24 ProductLAMPEIKEN CHEMICAL CO., LTD. Receives the 13th Zero Malaria Award
  • 2026.04.14 ProductVET-SAADriving the Future of Care: Prevention and Wellness First
  • 2026.03.24 CorporateReleaseWorld TB Day “Yes! We Can End TB. Led by countries. Powered by people.”
  • 2026.03.23 ProductLAMPNotice of Update to the LAMP Publications Page
  • 2026.02.27 ProductVET-SAAMeet us at ISACP 2026
  • 2026.02.26 CorporateReleaseNotice Concerning Introduction of C-Suite System and Changes in Executive Officers
  • 2026.02.09 ProductLAMPTB-LAMP Webinar Announcement Hosted by Stop TB Partnership

prev

  • 1
  • 2

next

  • Contact us
  • News
  • Site Map
  • Term of Use
  • Privacy Policy

Copyright(C) Eiken Chemical Co., Ltd. All Rights Reserved.

Eiken

We use cookies to improve your online experience of this website.
If you continue to browse without changing your settings, we will assume that you are agreeing to our use of cookies.
You can also click the "Agree" button to accept our policy, then this message does not appear in the future.
Full details are in our Privacy Policy.

Agree